Response Rate and Impact on Lipid Profiles of Obeticholic Acid Treatment for Patients with Primary Biliary Cholangitis: A Meta-Analysis

BACKGROUND: Up to 40% of patients with primary biliary cholangitis (PBC) have an inadequate response to ursodeoxycholic acid (UDCA). Obeticholic acid (OCA) is considered the addition of treatment, but the response rate based on commonly referenced biochemical response criteria and lipids' impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yuan, Li, Li, Li, Bei, Zhan, Yutao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822683/
https://www.ncbi.nlm.nih.gov/pubmed/33511089
http://dx.doi.org/10.1155/2021/8829510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822683/
https://www.ncbi.nlm.nih.gov/pubmed/33511089
http://dx.doi.org/10.1155/2021/8829510

Ejemplares similares